300146 Net Receivables from 2010 to 2025
| 300146 Stock | 11.87 0.05 0.42% |
Net Receivables | First Reported 2007-12-31 | Previous Quarter 318.8 M | Current Value 165.3 M | Quarterly Volatility 192.5 M |
Check By Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among By Health's main balance sheet or income statement drivers, such as Interest Expense of 7 M, Selling General Administrative of 2.8 B or Total Revenue of 3.7 B, as well as many indicators such as . 300146 financial statements analysis is a perfect complement when working with By Health Valuation or Volatility modules.
300146 | Net Receivables |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in 300146 Stock
By Health financial ratios help investors to determine whether 300146 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 300146 with respect to the benefits of owning By Health security.